• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W.L. GORE & ASSOCIATES GORE® EXCLUDER® AAA ENDOPROSTHESIS; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W.L. GORE & ASSOCIATES GORE® EXCLUDER® AAA ENDOPROSTHESIS; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT Back to Search Results
Catalog Number PXC141200
Device Problems Premature Activation (1484); Sticking (1597); Difficult to Advance (2920)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 12/22/2014
Event Type  Injury  
Event Description
On (b)(6) 2014, the patient was implanted with a gore® excluder® aaa endoprosthesis featuring c3® delivery system to treat an abdominal aortic aneurysm.The ipsilateral device was successfully deployed on the right side following probing difficulties of the contralateral leg.Subsequently, a crossover approach inside the trunk was attempted.It was not possible to advance a catheter into the contralateral leg from the left as the former got stuck at the gate.The fsa reported that the physician attempted to push the sheath as close as possible towards the main trunk but the gore® dryseal sheath 1828 appeared to be too short in view of the patient¿s height.The physician nevertheless attempted to access the gate by employing alternate rotating movements with the catheter.It was then decided to retracted the device.During the retraction process, the device accidentally experienced full deployment, unintentionally covering the left internal iliac artery but leaving a gap between the trunk and the contralateral leg.The deployment coincided with the simultaneous separation of the wire which was subsequently snared by the physician.The gap between the contralateral leg and the trunk was bridged.The patient was doing well following the procedure.The fsa reported of the physician's reassurance that at no time, there was great force employed when performing manipulations.The physician has substantial working experience with the excluder endoprosthesis.
 
Manufacturer Narrative
The review of the manufacturing paperwork verified that this lot met all pre-release specifications.
 
Manufacturer Narrative
(b)(4).The engineering evaluation has revealed the following: the guidewire and the introducer sheath used for the event were not returned, and are therefore unavailable for engineering evaluation.The returned delivery catheter for the product (pxc141200) exhibited polyimide guidewire lumen detachment at the leading end of the trailing olive junction.It appeared that the fracture was due to a polyimide guidewire lumen¿s tensile failure while the trailing olive junction remained intact.Based on the available information and evaluation of the returned portion of the product, the root cause for the polyimide detachment could not be determined at this time.This type of occurrence will continue to be trended and appropriate actions will be taken as they are deemed necessary.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GORE® EXCLUDER® AAA ENDOPROSTHESIS
Type of Device
SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT
Manufacturer (Section D)
W.L. GORE & ASSOCIATES
flagstaff AZ
Manufacturer (Section G)
MEDICAL SUNNYVALE B/P
1327 orleans drive
sunnyvale CA 94089
Manufacturer Contact
thomas giebing
1500 n. 4th street
flagstaff, AZ 86004
9285263030
MDR Report Key4431579
MDR Text Key5383756
Report Number2953161-2015-00008
Device Sequence Number1
Product Code MIH
Combination Product (y/n)N
Reporter Country CodeGM
PMA/PMN Number
P020004
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 01/29/2015
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date05/31/2017
Device Catalogue NumberPXC141200
Device Lot Number12763589
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer01/22/2015
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received Not provided
Initial Date FDA Received01/20/2015
Supplement Dates Manufacturer ReceivedNot provided
Supplement Dates FDA Received02/27/2015
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured07/09/2015
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
RLT281416, LOT# 12983014PXC141000, LOT# 10909980
Patient Outcome(s) Hospitalization; Required Intervention; Disability;
Patient Age75 YR
Patient Weight90
-
-